Febrile reactions to platelet transfusion: The effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method

Transfusion

Volumn 36, Issue 10, 1996, Pages 886-890

  Muylle, L ^a   Wouters, E ^a   Peetermans, M E ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; THROMBOCYTE CONCENTRATE;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; BLOOD STORAGE; BLOOD TRANSFUSION REACTION; FEMALE; FEVER; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; THROMBOCYTE RICH PLASMA; THROMBOCYTE TRANSFUSION;

EID: 0029801619     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.361097017174.x     Document Type: Article

References (37)

1. Muylle L, Wouters E, De Bock R, Peetermans ME. Reactions to platelet transfusion: the effect of the storase time of the concentrate. Transfus Med 1992;2:289-93.
2. Muylle L, Joos M, Wouters E, et al. Increased tumor necrosis factor a (TNF-a), interleukin 1, and interleukin 6 (1L-6) levels in the plasma of stored platelet concentrates: relationship between TNF-a and 1L-6 levels and febrile transfusion reactions. Transfusion 1993;33:195-9.
3. Dinarello CA, Cannon JG, Mier JW, et al. Multiple biological activities of human recombinant interleukin-1. J Clin Invest 1986;77:1734-9.
4. Muylle L, Peetermans ME. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang 1994;66:14-7.
5. Armitage P. Statistical methods in medical research. Blackwell, Oxford: 1994.
6. Bertolini F, Rebulla P, Ricardi D, et al. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucosefree crystalloid medium. Transfusion 1989;29:605-9.
7. Oksanen K, Ebeling F, Kekomäki R, et al. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat. Vox Sang 1994;67:356-61.
8. Guide to the preparation, use and quality assurance of blood components. Strasbourg: Council of Europe, 1992:69-78.
9. Novotny VM, Van Doom R, Rozier Y, et al. Transfusion results of filtered and subsequently stored random platelet suspensions prepared from buffy coats. Vox Sang 1992;63:23-30.
10. Miyamoto M, Sasakawa S, Ishikawa Y, et al. Leukocyte-poor platelet concentrates at the bedside by filtration through SepacellPL. Vox Sang 1989;57:164-7.
11. Kickler TS, Bell \V, Ness PM, et al. Depletion of white cells from platelet concentrates with a new adsorption filter. Transfusion 1989;29:411-4.
12. Perkins HA, Payne R, Ferguson J, Wood M. Nonhemolytic fcbrile transfusion reactions. Quantitative effects of blood components with emphasis on isoantigenic incompatibility of leukocytes. Vox Sang 1966; 11:578-600.
13. Hirano T. Interleukin-6. In: Thomson AW, ed. The cytokine handbook. London: Academic Press, 1991:169-90.
14. Nijsten MW, de Groot ER, Ten Duis HJ, et al. Serum levels of interleukin-6 and acute phase responses (letter). Lancet 1987;2:921.
15. Stack G, Snyder EL. Cytokine generation in stored platelet concentrates. Transfusion 1994;34:20-5.
16. Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-8.
17. Yuo A, Kitagawa S, Kasahara T, et al. Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood 1991;78:2708-14.
18. Hawrylowicz CM. Viewpoint: a potential role for platelet derived cytokines in the inflammatory response. Platelets 1993;4:1-10.
19. Muylle L, Laekeman G, Herman AG, Peetermans ME. Histamine levels in stored platelet concentrates. Relationship to white cell content. Transfusion 1988;28:226-8.
20. Silliman CC, Thurman GW, Ambruso DR. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating-factor receptor. Vox Sang 1992;63:133-6.
21. Vercellotti GM, Yin HQ, Gustafson KS, et al. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood 1988;71:1100-7.
22. Pitman JM, Thurman GW, Anderson BO, et al. WEB2170, a specific platelet-activating factor antagonist, attenuates neutrophil priming by human serum after clinical bum injury: the 1991 Moyer Award. J Burn Care Rehabil 1991;12:411-9.
23. Anderson BO, Brown JM, Harken AH. Mechanisms of neutrophil-mediated tissue injury. J SurgRes 1991 ;51:170-9.
24. Blombäck M,-Chmiele\vska J, Netré C, Akerblom O. Activation of blood coagulation, fibrinolytic and kallikrein systems during storage of plasma. Vox Sang 1984;47:335-42.
25. Bode AP, Miller DT. Generation and degradation of fibrinopeptide A in stored platelet concentrate. Vox Sang 1986;51:192-6.
26. Bode AP, Miller DT, Newman S. Generation of complement activation peptides during storage of platelet concentrates (PC). Thromb Haemost 1987;58:512.
27. Miletic VD, Popovic O. Complement activation in stored platelet concentrates. Transfusion 1993;33:150-4.
28. Chenoweth DE, Hugli TE. Demonstration of a specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sei U S A 1978;75:3943-7.
29. Lo SK, Lai L, Cooper JA, Malik AB. Thrombin-induced generation of neutrophil activating factors in blood. Am J Pathol 1988;130:22-32.
30. Wachtfogel YT, Pixley RA, Kucich U, et al. Purified plasma factor XHa aagregates human neutrophils and causes degranulation. Blood 1986;67:1731-7.
31. Kaplan AP, Kay AB, Austen KF. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. JExpMedl972;135:81-97.
32. Fijnheer R, Modderman PW, Veldman H, et al. Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage. Transfusion 1990;30:20-5.
33. Rinder HM, Snyder EL, Bonan JL, et al. Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein Hb/IIla, and -thromboglobulin release. Transfusion 1993;33:25-9.
34. Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990;75:550-4.
35. De Bruijne-Admiraal LG, Modderman PW, Von dem Borne AE, Sonnenberg A. P-selectin mediates Ca2+-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood 1992;80:134-42.
36. Ruf A, Schlenk RF, Maras A, et al. Contact-induced neutrophil activation by platelets in human cell suspensions and whole blood. Blood 1992;80:1238-46.
37. Dzik WH. Is the febrile response to transfusion due to donor or recipient cytokine? (letter). Transfusion 1992;32:594.